BioMedPartners of Switzerland said that it has closed its second healthcare venture capital fund, BioMedInvest II, at CHF 106 million (€71.7 million). The new fund will invest in private, early to mid-stage healthcare companies in Europe.
BioMedPartners of Switzerland said that it has closed its second healthcare venture capital fund, BioMedInvest II, at CHF 106 million (€71.7 million). The new fund will invest in private, early to mid-stage healthcare companies in Europe.